Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03275974 · ClinicalTrials.gov registry record · Phase 1
Glutamine PET Imaging Colorectal Cancer
A Phase 1 study, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT03275974: Clinical Trial Phase 1 study, sponsored by M.D. Anderson Cancer Center.
NCT03275974 is a Phase 1 study that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 6 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03275974, a Phase 1 study, was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
The clinical trial studies how well 11C-glutamine and 18F-FSPG positron emission tomography (PET) imaging works in detecting tumors in patients with metastatic colorectal cancer compared to standard imaging methods such as magnetic resonance imaging (MRI) or computed tomography (CT) scanning.
Primary Outcome
Assessed in terms of Standardized Uptake Values (SUVs)
Interventions
- PROCEDURE Positron Emission Tomography
- PROCEDURE Blood Draw
- BIOLOGICAL Carbon C 11 Glutamine
- BIOLOGICAL Fluorine F 18 L-glutamate Derivative BAY94-9392
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2021-04-27 |
| Est. Completion | 2025-12-23 |
| Phase | Phase 1 |
Why NCT03275974 stopped before completion
NCT03275974 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 4 interventions - of which Positron Emission Tomography is the first listed.
NCT03275974 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03275974 about?
NCT03275974 is a clinical study titled "Glutamine PET Imaging Colorectal Cancer". The clinical trial studies how well 11C-glutamine and 18F-FSPG positron emission tomography (PET) imaging works in detecting tumors in patients with metastatic colorectal cancer compared to standard imaging methods such as magnetic resonance imaging (MRI) or computed tomography (CT) scanning.
What is the current status of trial NCT03275974?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2021-04-27. Estimated completion is 2025-12-23.
What interventions are being tested in trial NCT03275974?
The interventions under investigation include: Positron Emission Tomography (PROCEDURE), Blood Draw (PROCEDURE), Carbon C 11 Glutamine (BIOLOGICAL), Fluorine F 18 L-glutamate Derivative BAY94-9392 (BIOLOGICAL).
Who is sponsoring clinical trial NCT03275974?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03275974's enrollment target sits among peer trials
6 1974th of 2000 higher than 12 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI